These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways. Guerrero F; Herencia C; Almadén Y; Martínez-Moreno JM; Montes de Oca A; Rodriguez-Ortiz ME; Diaz-Tocados JM; Canalejo A; Florio M; López I; Richards WG; Rodriguez M; Aguilera-Tejero E; Muñoz-Castañeda JR PLoS One; 2014; 9(2):e89179. PubMed ID: 24586576 [TBL] [Abstract][Full Text] [Related]
24. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862 [TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY; Xue M; Zhang QC; Su CF Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584 [TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Papathanasiou I; Malizos KN; Tsezou A Arthritis Res Ther; 2012 Apr; 14(2):R82. PubMed ID: 22513174 [TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. Raida M; Clement JH; Leek RD; Ameri K; Bicknell R; Niederwieser D; Harris AL J Cancer Res Clin Oncol; 2005 Nov; 131(11):741-50. PubMed ID: 16136355 [TBL] [Abstract][Full Text] [Related]
30. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523 [TBL] [Abstract][Full Text] [Related]
31. Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. Laezza C; D'Alessandro A; Paladino S; Maria Malfitano A; Chiara Proto M; Gazzerro P; Pisanti S; Santoro A; Ciaglia E; Bifulco M; Eur J Cancer; 2012 Nov; 48(16):3112-22. PubMed ID: 22425263 [TBL] [Abstract][Full Text] [Related]
32. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565 [TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779 [TBL] [Abstract][Full Text] [Related]
34. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
35. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells. Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276 [TBL] [Abstract][Full Text] [Related]
36. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945 [TBL] [Abstract][Full Text] [Related]
37. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510 [TBL] [Abstract][Full Text] [Related]
38. Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells. Mauvoisin D; Charfi C; Lounis AM; Rassart E; Mounier C Cancer Sci; 2013 Jan; 104(1):36-42. PubMed ID: 23013158 [TBL] [Abstract][Full Text] [Related]
39. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling. Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334 [TBL] [Abstract][Full Text] [Related]
40. HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin. Yu N; Kakunda M; Pham V; Lill JR; Du P; Wongchenko M; Yan Y; Firestein R; Huang X Mol Cell Biol; 2015 Apr; 35(8):1390-400. PubMed ID: 25645927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]